NCT01856153

Brief Summary

Primary objective is to determine if the efficacy of strawberries delivering polyphenols to prevent metabolic inflammation will be influenced by timing of consumption relative to meal intake. Secondary objective is to characterize the relative bioavailability and absorption profile of strawberry polyphenols consumed with meal or at alternatives times around a meal (2 hours before the meal ad 2 hours after the meal). Third objective is to determine the bioavailability/absorption profile of strawberry polyphenols and its relationship with the anti-inflammatory mechanism of action of strawberry constituents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 17, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

July 27, 2021

Status Verified

July 1, 2021

Enrollment Period

9 months

First QC Date

May 3, 2013

Last Update Submit

July 26, 2021

Conditions

Keywords

BioavailabilityStrawberry polyphenolsTime Influence

Outcome Measures

Primary Outcomes (1)

  • Changes in plasma polyphenol concentrations over 10 hours after strawberry beverage consumption at different time points.

    The timing influence of strawberry consumption on bioavailability of strawberry polyphenols in relative to meal intake (2 hours before a meal, with a meal, and 2 hours after a meal).

    10 hours

Secondary Outcomes (1)

  • Changes in inflammation markers over 10 hours after strawberry beverage consumption at different time points.

    10 hours

Other Outcomes (2)

  • Changes in oxidative stress markers over 10 hours after strawberry beverage consumption at different time points.

    10 hours

  • Changes in metabolic markers over 10 hours after strawberry beverage consumption at different time points.

    10 hours

Study Arms (3)

Before meal

OTHER

Strawberry-Placebo-Placebo

Dietary Supplement: Before meal

With Meal

OTHER

Placebo-Strawberry-Placebo

Dietary Supplement: With Meal

After Meal

OTHER

Placebo-Placebo-Strawberry

Dietary Supplement: After meal

Interventions

Before mealDIETARY_SUPPLEMENT
Before meal
With MealDIETARY_SUPPLEMENT
With Meal
After mealDIETARY_SUPPLEMENT
After Meal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age and older
  • Body Mass Index (BMI) range from 25 to 29.9 kg/m2; exception BMI 23 to 27.4 kg/m2 for Asian population
  • Nonsmoker
  • No clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease
  • Not taking any medications that would interfere with outcomes of the study, i.e. lipid lowering medications, anti-inflammatory drugs, or dietary supplements.
  • Able to provide informed consent
  • Able to comply and perform the procedures requested by the protocol
  • Weight stable: not gained or lost weight +/- 5 kg in previous 3 months

You may not qualify if:

  • Men and women who smoke
  • Past smokers: abstinence for minimum 2 years
  • Men and women with known or suspected food intolerance, allergies or hypersensitivity
  • Men and women known to have/diagnosed with diabetes mellitus
  • Men and women who have fasting blood glucose concentrations \> 125mg/dL
  • Men and women who have uncontrolled blood pressure \>140 mmHg/90 mmHg
  • Men and women with documented vascular disease, e.g., heart failure, myocardial infarction, stroke, angina, related surgeries.
  • Men and women with cancer other than non-melanoma skin cancer in previous 5 years.
  • Women who are known to be pregnant or who are intending to become pregnant over the course of the study
  • Women who are lactating
  • Taking medication or dietary supplements that may interfere with the outcomes of the study; e.g., antioxidant supplement, anti-inflammation, lipid lowering medication. Subjects may choose to go off dietary supplements (requires 30 days washout).
  • Men and women who have donated blood within 3 months of the screening visit and blood donors/participants for whom participation in this study will result in having donated more than 1500 milliliters of blood in the previous 12 months.
  • Men and women who are vegans
  • Substance (alcohol or drug) abuse within the last 2 years.
  • Excessive coffee and tea consumers (\> 4 cups/d)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Nutrition Research Center

Chicago, Illinois, 60616, United States

Location

MeSH Terms

Conditions

Overweight

Interventions

MealsPostprandial Period

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesDigestive System Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Britt Burton-Freeman, Ph.D

    Illinois Institute of Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2013

First Posted

May 17, 2013

Study Start

July 1, 2013

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

July 27, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations